Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 15 June 2007. doi:10.1136/thx.2006.069310
Thorax 2007;62:950-956
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow web only appendix
Right arrow All Versions of this Article:
thx.2006.069310v1
62/11/950    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogiatzis, I.
Right arrow Articles by Zakynthinos, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogiatzis, I.
Right arrow Articles by Zakynthinos, S.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Effects of rehabilitative exercise on peripheral muscle TNF{alpha}, IL-6, IGF-I and MyoD expression in patients with COPD

Ioannis Vogiatzis1, Grigoris Stratakos2, Davina C M Simoes2, Gerasimos Terzis1, Olga Georgiadou2, Charis Roussos2, Spyros Zakynthinos2

1 National and Kapodistrian University of Athens, Department of Physical Education and Sport Science, Athens, Greece
2 National and Kapodistrian University of Athens, Department of Critical Care Medicine and Pulmonary Services, Pulmonary Rehabilitation Centre, Evangelismos Hospital, G.P. Livanos and M. Simou Laboratories, Athens, Greece

Correspondence to:
Dr Ioannis Vogiatzis, National and Kapodistrian University of Athens – Thorax Foundation, 3 Ploutarhou Str 106 75, Athens, Greece; gianvog{at}phed.uoa.gr

Background: Skeletal muscle wasting commonly occurs in patients with chronic obstructive pulmonary disease (COPD) and has been associated with the presence of systemic inflammation. This study investigated whether rehabilitative exercise training decreases the levels of systemic or local muscle inflammation or reverses the abnormalities associated with muscle deconditioning.

Methods: Fifteen patients with COPD (mean (SE) forced expiratory volume in 1 s 36 (4)% predicted) undertook high-intensity exercise training 3 days/week for 10 weeks. Before and after the training programme the concentration of tumour necrosis factor {alpha} (TNF{alpha}), interleukin-6 (IL-6) and C-reactive protein (CRP) in plasma was determined by ELISA, and vastus lateralis mRNA expression of TNF{alpha}, IL-6, total insulin-like growth factor-I (IGF-I) and its isoform mechanogrowth factor (MGF) and myogenic differentiation factor D (MyoD) were assessed by real-time PCR. Protein levels of TNF{alpha}, IGF-I and MyoD were measured by Western blotting.

Results: Rehabilitation improved peak exercise work rate by 10 (2%) (p = 0.004) and mean fibre cross-sectional area from 4061 (254) µm2 to 4581 (241) µm2 (p = 0.001). Plasma inflammatory mediators and vastus lateralis expression of TNF{alpha} and IL-6 were not significantly modified by training. In contrast, there was a significant increase in mRNA expression of IGF-I (by 67 (22)%; p = 0.044), MGF (by 67 (15)%; p = 0.002) and MyoD (by 116 (30)%; p = 0.001). The increase observed at the mRNA level was also seen at the protein level for IGF-I (by 72 (36)%; p = 0.046) and MyoD (by 67 (21)%; p = 0.012).

Conclusions: Pulmonary rehabilitation can induce peripheral muscle adaptations and modifications in factors regulating skeletal muscle hypertrophy and regeneration without decreasing the levels of systemic or local muscle inflammation.


Abbreviations: COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IGF-I, insulin-like growth factor-I; IL, interleukin; MGF, mechanogrowth factor; MyoD, myogenic differentiation factor D; TNF{alpha}, tumour necrosis factor {alpha}







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society